Investigators from Mass General Brigham have developed a way to promote antitumor immunity by hijacking cellular machinery within cancer cells.
ScienceAlert on MSN
'Young' Immune Cells Partly Reverse Alzheimer's Symptoms in Mice
Specially engineered 'young' immune cells could help to reverse the effects of aging and the damage to brain cells caused by ...
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...
A longevity expert reveals how immune systems begin aging after 35, making people more susceptible to infections and immune-related disorders over time.
Pregnancy and breastfeeding leave behind long-lived CD8+ T cells that can persist for decades, providing lasting immune ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Ben-Gurion University of the Negev's Prof. Alon Monsonego had discovered that T helper lymphocytes, a subset of immune cells ...
With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...
Gastrointestinal (GI) complications are common in patients with Inborn Errors of Immunity (IEI), and include various infections, autoimmune conditions like ...
The field of bacteriophage research is rapidly evolving, offering new perspectives on the complex interplay between phages, bacteria, and host immune ...
Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.
The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results